It's finally out as a paper :D
🧵1/ Introducing scifer, our R/Bioconductor package developed with B cell receptor (BCR) sequences in mind, but adaptable to other sequence types. Pre-trained on real datasets, scifer is designed to streamline index cell sorting sequencing workflow
This year’s #NobelPrize laureates in chemistry have revealed proteins’ secrets through computing and artificial intelligence.
Chemists have long dreamed of fully understanding and mastering the chemical tools of life – proteins. This dream is now within reach. 2024 chemistry laureates Demis Hassabis and John M. Jumper have successfully utilised artificial intelligence to predict the structure of almost all known proteins. This year’s chemistry laureate David Baker has learned how to master life’s building blocks and create entirely new proteins. The potential of their discoveries is enormous.
The ability to create proteins that are loaded with new functions is just as astounding. This can lead to new nanomaterials, targeted pharmaceuticals, more rapid development of vaccines, minimal sensors and a greener chemical industry – to name just a few applications that are for the greatest benefit of humankind.
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
We want to extend our warm congratulations to 2023 @NobelPrize Laureates Katalin Karikó and Drew Weissman! It was an honor to publish their key findings for the Physiology or Medicine prize: https://t.co/AqhPFAe5jG @kkariko@WeissmanLab@pennmedicine#NobelPrize
Happy to share our latest publication @ImmunityCP: Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
https://t.co/vQteifxPcT
Online now: Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses https://t.co/ql5CCpa2bL
It's an incredible day for structure-based vaccine design, and I'm thrilled to see our prefusion RSV F antigen get approved as the first RSV vaccine. Still more work to do to reduce the RSV disease burden, but this will help! Congrats @BarneyGrahamMD! https://t.co/8L5JaNy49o
Super happy and proud to share that I am one of the recipients of the KI Sven Gard Prize for the best virology doctoral thesis during 2022.
https://t.co/IW7Pf2MSn5